Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings Channel reports. The firm bought 13,020 shares of the company’s stock, valued at approximately $268,000. A number of other hedge funds also recently made changes to their positions in NTLA. ARK Investment Management LLC increased […]
More Stories
IDEX (IDEX) One Day Volume Tops $3.19 Million
IDEX (IDEX) traded down 0.9% against the U.S. dollar during the 24 hour period ending at 13:00 PM ET on...
Loom Network Market Cap Hits $79.27 Million (LOOM)
Loom Network (LOOM) traded 0.8% lower against the US dollar during the 1 day period ending at 13:00 PM Eastern...
Orchid Trading Up 9% Over Last Week (OXT)
Orchid (OXT) traded 5% lower against the dollar during the 24 hour period ending at 13:00 PM E.T. on November...
Thompson Siegel & Walmsley LLC Has $13.39 Million Stake in Amgen Inc. (NASDAQ:AMGN)
Thompson Siegel & Walmsley LLC grew its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.4% during the third...
Massachusetts Financial Services Co. MA Lowers Position in Air Products and Chemicals, Inc. (NYSE:APD)
Massachusetts Financial Services Co. MA reduced its stake in Air Products and Chemicals, Inc. (NYSE:APD – Free Report) by 2.0%...
Guggenheim Issues Positive Forecast for Elastic (NYSE:ESTC) Stock Price
Elastic (NYSE:ESTC – Get Free Report) had its price target upped by investment analysts at Guggenheim from $100.00 to $120.00...